Proper DRG Assignments Should Precede Bonus Payment Decisions – Industry
This article was originally published in The Gray Sheet
Executive Summary
Device firms large and small maintain that Medicare can curb the need for new-technology "add-on" payments by placing primary emphasis on appropriate diagnosis-related group (DRG) assignments
You may also be interested in...
CorCap Efficacy Data Deemed Scant By Panel; Acorn Vows Not To Lose Heart
Acorn Cardiovascular will work with FDA to address panel concerns with CorCap that arose during a June 22 meeting to review the ventricular support device
Medtronic Bone Graft Reimbursement Fate Fused With Stryker’s In CMS Rule
CMS' proposed decision to deny a new-technology add-on to Medtronic's InFuse bone graft reaffirms that "substantial clinical improvement" ranks last in the hierarchy of evidence required for the payment
Is CMS Charitably Inclined Toward DePuy Spine Disc? Other Payors Take Heed
Johnson & Johnson/DePuy will submit hospital claims data to CMS in an effort to convince the agency that the Charité artificial spine disc yields better outcomes for Medicare patients when compared with fusion